Liga Portuguesa Contra o Cancro – Núcleo Regional do Centro

LPCC-NRC

The Portuguese Cancer League (Liga Portuguesa Contra o Cancro – LPCC) is a private non-profit non-governmental organization, declared by law of public utility (relevant social aim), founded in April 1941.
The League activities are developed by 5 branches with head offices in Angra do Heroísmo (Azores island branch), Coimbra (central branch), Funchal (Madeira island branch), Lisbon (south branch), Oporto (north branch). The Branches are responsible for the development of the League activities in their regions.
The League major fields of activity are: Health education and cancer prevention (all levels); Support for cancer survivors, families and carers; Promoting research in oncology (basic, translational, clinical and epidemiological); National Breast Cancer Screening Program; Fundraising.

 

Role of institution in the project

WP7 – Use cases for platform expansion and validation

The first breast cancer screening (BCS) activity held in Portugal consisted of a pilot-test conducted by the LPCC in 18 counties from 1986 to June 1990. With almost 40 years of activity, the LPCC has technical and scientific expertise as well as unique experience in this area of preventive medicine. It has had a significant digital mammography database (PACS) (since 2008) with radiological classification (BIRADS) and hospital diagnosis and treatment results. In 2024, a pilot project was started to introduce AI into the radiology reading process, with a retrospective and prospective study.

Vitor Jose Lopes Rodrigues

MD in 1981 and PhD in Preventive Medicine and Public Health in 1993. Retired Professor at the Faculdade de Medicina (Universidade de Coimbra – Portugal) of Epidemiology, Biostatistics, Health Economics (under-graduate and post-graduate courses) Coordinator of Breast Cancer Screening Programme in Central Region of Portugal Consultant of the Azores Government for Oncologic screening programmes Scientific Coordinator of the Azores Region Cancer registry Member of European and International Screening Networks, namely ECIBC (European Commission Iniciative on Breast Cancer) Scientific prodution – see ORCID Past National Presidente of the Liga Portuguesa contra o Cancro (LPCC) Presidente of the Central Branch of the LPCC

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Find out more

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

WATCH THE RECORDING

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

Sign up for more information

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.

Participate